Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (371-380 of 522) with videos related to

Pageof 53
Sort By:
European Urology|April 13, 2017
Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic FeaturesR Jeffrey Karnes, Voleak Choeurng, Ashley E Ross, et al.
Clinical Genitourinary Cancer|January 17, 2017
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate CancerJennifer M Lobo, Daniel M Trifiletti, Vanessa N Sturz, et al.
European Urology Oncology|June 4, 2021
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is LimitedUmberto Capitanio, Riccardo Autorino, Marco Bandini, et al.
The Prostate|October 11, 2017
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCHZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial CancerVadim S Koshkin, Vipul Kumar, Brad Kline, et al.
European Urology Focus|May 15, 2025
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional CohortKevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
Prostate Cancer and Prostatic Diseases|August 8, 2023
The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statementJuan Javier-DesLoges, Marc A Dall'Era, Wayne Brisbane, et al.
Cancer|November 15, 2018
Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?Adriana C Vidal, Lauren E Howard, Amanda De Hoedt, et al.
The Prostate|September 30, 2016
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH DatabaseZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Cancer|June 5, 2020
Obesity, race, and long-term prostate cancer outcomesAdriana C Vidal, Taofik Oyekunle, Lauren E Howard, et al.
Pageof 53

Showing results (371-380 of 522) with videos related to

Sort By:
Pageof 53
European Urology|April 13, 2017
Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic FeaturesR Jeffrey Karnes, Voleak Choeurng, Ashley E Ross, et al.
Clinical Genitourinary Cancer|January 17, 2017
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate CancerJennifer M Lobo, Daniel M Trifiletti, Vanessa N Sturz, et al.
European Urology Oncology|June 4, 2021
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is LimitedUmberto Capitanio, Riccardo Autorino, Marco Bandini, et al.
The Prostate|October 11, 2017
Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCHZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Initial Experience with <sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial CancerVadim S Koshkin, Vipul Kumar, Brad Kline, et al.
European Urology Focus|May 15, 2025
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional CohortKevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
Prostate Cancer and Prostatic Diseases|August 8, 2023
The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statementJuan Javier-DesLoges, Marc A Dall'Era, Wayne Brisbane, et al.
Cancer|November 15, 2018
Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?Adriana C Vidal, Lauren E Howard, Amanda De Hoedt, et al.
The Prostate|September 30, 2016
Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH DatabaseZachary S Zumsteg, Zinan Chen, Lauren E Howard, et al.
Cancer|June 5, 2020
Obesity, race, and long-term prostate cancer outcomesAdriana C Vidal, Taofik Oyekunle, Lauren E Howard, et al.
Pageof 53